National Heart, Lung, and Blood Institute; Notice of Closed Meetings, 83858-83859 [2016-27996]
Download as PDF
<![CDATA[
83858
Federal Register / Vol. 81, No. 225 / Tuesday, November 22, 2016 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Centers for AIDS Research
and Developmental Centers for AIDS
Research (P30).
Date: December 12–13, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Roberta Binder, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Room 3G21A, National Institutes of Health/
NIAID, 5601 Fishers Lane, MSC 9823,
Bethesda, MD 20892–9823, (240) 669–5050,
rbinder@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: November 16, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–28042 Filed 11–21–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
sradovich on DSK3GMQ082PROD with NOTICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
VerDate Sep<11>2014
16:52 Nov 21, 2016
Jkt 241001
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Fellowship:
Infectious Diseases and Microbiology.
Date: November 29, 2016.
Time: 3:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Alexander D. Politis,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3210,
MSC 7808, Bethesda, MD 20892, (301) 435–
1150, politisa@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–AA–
17–006: U.S.-Russia Bilateral Collaborative
Research Partnerships.
Date: December 1, 2016.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Robert Freund, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5216,
MSC 7852, Bethesda, MD 20892, 301–435–
1050, freundr@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–AA–
17–006: U.S.-Russia Bilateral Collaborative
Research Partnerships.
Date: December 1, 2016.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Robert Freund, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5216,
MSC 7852, Bethesda, MD 20892, 301–435–
1050, freundr@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: November 15, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–27994 Filed 11–21–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
CLTR SEP Review.
Date: December 1, 2016.
Time: 10:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Room 7188, Bethesda, MD
20892 (Telephone Conference Call).
Contact Person: Chang Sook Kim, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7188, Bethesda, MD 20892–7924, 301–435–
0287, carolko@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
NHLBI TOPMed: Integrative Omics
Approaches for Analysis of TOPMed Data.
Date: December 2, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The River Inn, 924 25th Street NW.,
Washington, DC 20037.
Contact Person: Susan Wohler Sunnarborg,
Ph.D., Scientific Review Officer, Office of
Scientific Review/DERA, National, Heart,
E:\FR\FM\22NON1.SGM
22NON1
Federal Register / Vol. 81, No. 225 / Tuesday, November 22, 2016 / Notices
Lung, and Blood Institute, 6701 Rockledge
Drive, Room 7182, Bethesda, MD 20892
sunnarborgsw@nhlbi.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: November 15, 2016.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–27996 Filed 11–21–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
sradovich on DSK3GMQ082PROD with NOTICES
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
VerDate Sep<11>2014
16:52 Nov 21, 2016
Jkt 241001
Proposed Project: Community Mental
Health Services Block Grant and
Substance Abuse and Prevention
Treatment Block Grant FY 2018–2019
Plan and Report Guidance and
Instructions (OMB No. 0930–0168)—
Revision
The Substance Abuse and Mental
Health Services Administration
(SAMHSA) is requesting approval from
the Office of Management and Budget
(OMB) for a revision of the 2016–17
Community Mental Health Services
Block Grant (MHBG) and Substance
Abuse Prevention and Treatment Block
Grant (SABG) Plan and Report Guidance
and Instructions.
Currently, the SABG and the MHBG
differ on a number of their practices
(e.g., data collection at individual or
aggregate levels) and statutory
authorities (e.g., method of calculating
MOE, stakeholder input requirements
for planning, set asides for specific
populations or programs, etc.).
Historically, the Centers within
SAMHSA that administer these block
grants have had different approaches to
application requirements and reporting.
To compound this variation, states have
different structures for accepting,
planning, and accounting for the block
grants and the prevention set aside
within the SABG. As a result, how these
dollars are spent and what is known
about the services and clients that
receive these funds varies by block grant
and by state.
Increasingly, under the Affordable
Care Act, more individuals are eligible
for Medicaid and private insurance.
This expansion of health insurance
coverage will continue to have a
significant impact on how State Mental
Health Authorities (SMHAs) and Single
State Agencies (SSAs) use their limited
resources. In 2009, more than 39 percent
of individuals with serious mental
illnesses (SMI) or serious emotional
disturbances (SED) were uninsured.
Sixty percent of individuals with
substance use disorders whose
treatment and recovery support services
were supported wholly or in part by
SAMHSA block grant funds were also
uninsured. A substantial proportion of
this population has gained health
insurance coverage since enactment of
the Affordable Care Act and now has
various outpatient and other services
covered through Medicaid, Medicare, or
private insurance. However, coverage
provided by these plans and programs
do not necessarily provide access to the
full range of support services needed to
achieve and maintain recovery for most
of these individuals and their families.
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
83859
Given these changes, SAMHSA has
conveyed that block grant funds be
directed toward four purposes: (1) To
fund priority treatment and support
services for individuals without
insurance or who cycle in and out of
health insurance coverage; (2) to fund
those priority treatment and support
services not covered by Medicaid,
Medicare or private insurance offered
through the exchanges and that
demonstrate success in improving
outcomes and/or supporting recovery;
(3) to fund universal, selective and
targeted prevention activities and
services; and (4) to collect performance
and outcome data to determine the
ongoing effectiveness of behavioral
health prevention, treatment and
recovery support services and to plan
the implementation of new services on
a nationwide basis.
To help states meet the challenges of
2018 and beyond, and to foster the
implementation and management of an
integrated physical health and mental
health and addiction service system,
SAMHSA must establish standards and
expectations that will lead to an
improved system of care for individuals
with or at risk of mental and substance
use disorders. Therefore, this
application package includes fully
exercising SAMHSA’s existing authority
regarding states’, territories’ and the Red
Lake Band of the Chippewa Tribe’s
(subsequently referred to as ‘‘states’’)
use of block grant funds as they fully
integrate behavioral health services into
the broader health care continuum.
Consistent with previous
applications, the FY 2018–2019
application has sections that are
required and other sections where
additional information is requested. The
FY 2018–2019 application requires
states to submit a face sheet, a table of
contents, a behavioral health assessment
and plan, reports of expenditures and
persons served, an executive summary,
and funding agreements and
certifications. In addition, SAMHSA is
requesting information on key areas that
are critical to the states success in
addressing health care integration.
Therefore, as part of this block grant
planning process, SAMHSA is asking
states to identify both their promising or
effective strategies as well as their
technical assistance needs to implement
the strategies they identify in their plans
for FYs 2018 and 2019.
To facilitate an efficient application
process for states in FYs 2018–2019,
SAMHSA convened an internal
workgroup to review and modify the
application for the block grant planning
section. In addition, SAMHSA utilized
the questions and requests for
E:\FR\FM\22NON1.SGM
22NON1
]]>Agencies
[Federal Register Volume 81, Number 225 (Tuesday, November 22, 2016)]
[Notices]
[Pages 83858-83859]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-27996]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; CLTR SEP Review.
Date: December 1, 2016.
Time: 10:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive, Room
7188, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Chang Sook Kim, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room 7188, Bethesda, MD
20892-7924, 301-435-0287, carolko@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; NHLBI TOPMed: Integrative Omics Approaches
for Analysis of TOPMed Data.
Date: December 2, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The River Inn, 924 25th Street NW., Washington, DC 20037.
Contact Person: Susan Wohler Sunnarborg, Ph.D., Scientific
Review Officer, Office of Scientific Review/DERA, National, Heart,
[[Page 83859]]
Lung, and Blood Institute, 6701 Rockledge Drive, Room 7182,
Bethesda, MD 20892 sunnarborgsw@nhlbi.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: November 15, 2016.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-27996 Filed 11-21-16; 8:45 am]
BILLING CODE 4140-01-P
